Clinical Trial Update: Angiotensin-(1-7) and Energy Expenditure in Human Obesity [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating Angiotensin-(1-7) for energy expenditure in obesity; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Amy Arnold | Conditions: Obesity | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING